Skip to main content

Development and clinical validation of novel smart device to provide real-time ablation + tissue analysis through advanced 4D imaging to enable >90% success rate in Atrial Fibrillation treatment

Objective

OneProjects is a new medical device company based in Dublin and Munich developing the new wave of disruptive cardiac imaging
innovations that will provide a sea change in the treatment of atrial fibrillation (AFib) through ablation. With the clinical need at the
core of our mission and world-class expertise in medical imaging and product commercialisation, OneProjects is developing
VERAFEYE, a novel smart catheter system that provides real-time 4D ablation/tissue analysis and navigation enabled through
advanced imaging and analytics.
VERAFEYE is a breakthrough connected technology which can generate unprecedented 4D data during the ablation procedure, thus
providing the physician with real-time analysis of the surgery. VERAFEYE will for the first time allow clinicians to correct and enhance
the treatment in the 1st procedure, ensuring the patient is AFib free, and hence remove the need for multiple surgeries. VERAFEYE
will shift treatment to the era of evidence- and data-based success rather than purely relying on the experience of the
electrophysiologist as is currently the case.

Field of science

  • /medical and health sciences/clinical medicine/surgery
  • /medical and health sciences/clinical medicine/radiology/medical imaging

Call for proposal

H2020-EIC-SMEInst-2018-2020-3
See other projects for this call

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)

Coordinator

ONEPROJECTS DESIGN INNOVATION LIMITED
Address
Suite 7 Argus House Greenmount Office Park Horolds Cross
D6WPP38 Dublin
Ireland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 2 500 000